Status:
COMPLETED
Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines
Lead Sponsor:
Novartis Vaccines
Conditions:
Influenza
Eligibility:
All Genders
18-39 years
Phase:
PHASE1
Brief Summary
This trial is designed to evaluate safety, tolerability and immunogenicity of a bedside mixing formulation of adjuvanted influenza vaccines.
Eligibility Criteria
Inclusion
- Healthy 18 to 39 year old males and females who are in good health and have provided informed consent prior to enrollment
Exclusion
- serious medical conditions
- allergies to vaccine components, including but not limited to egg/chicken products
- reduced immune function
- recent use of immunosuppressive therapy
- recent use of influenza vaccine
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00735020
Start Date
June 1 2008
End Date
August 1 2008
Last Update
January 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
I.P.A.S.
Ligornetto, Switzerland, 36 6853